Unlocking the Promise of Genome Editing to DeliverĀ Life-Changing Medicines

Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Read More


Latest News

July 1, 2015
Editas Medicine Appoints Andrew Hack, M.D., Ph.D., as Chief Financial Officer Read More